
Masayuki Nigo MD
Houston Methodist Hospital, Texas Medical Center
Join to view full profile
6560 Fannin StreetSuite 1540Houston, TX 77030
Phone+1 713-799-9997
Fax+1 713-799-2511
Dr. Nigo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2013 - 2015
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2010 - 2013
OtherClass of 2005
Certifications & Licensure
TX State Medical License 2016 - 2028
MA State Medical License 2012 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Comparative adjuvant therapy to reduce vancomycin-associated nephrotoxicity in an animal model.Yongqi Xiao, Nicholas S Teran, Cole S Hudson, Masayuki Nigo, Vincent H Tam
Antimicrobial Agents and Chemotherapy. 2026-09-10 - Contemporary Trends in Candidemia: Mortality, Species, and Antifungal Resistance Across Three Periods (2017-2025) in Houston, Texas.Mary North Jones, Masayuki Nigo, María Alejandra Pérez, Stefano Casarin, Aarjav Sanghvi
Open Forum Infectious Diseases. 2026-09-01 - Artificial intelligence in antimicrobial stewardship: prediction, clinical applications, and implementation challenges.Takahiro Matsuo, Masayuki Nigo, Fabio Borgonovo, Hisato Yoshida, Aaron J Tande
Clinical Microbiology and Infection. 2026-07-28
Press Mentions
For Many COVID-19 Patients, ‘Recovered’ Doesn’t Mean the Fight Is OverJuly 15th, 2020
New Houston Methodist Study Shows How AI Can Assist Clinicians in Identifying High-Risk Patients with Bloodstream Infection and Offer Better Chance of SurvivalMarch 10th, 2026
Grant Support
- Deep Learning Based Pharmacokinetic Model for VancomycinMETHODIST HOSPITAL RESEARCH INSTITUTE2023–2028
Professional Memberships
- Associate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: